192 related articles for article (PubMed ID: 38750559)
1. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis.
Ho YK; Woo JY; Loke KM; Deng LW; Too HP
J Transl Med; 2024 May; 22(1):463. PubMed ID: 38750559
[TBL] [Abstract][Full Text] [Related]
2. Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice.
Khatri A; Zhang B; Doherty E; Chapman J; Ow K; Pwint H; Martiniello-Wilks R; Russell PJ
J Gene Med; 2006 Sep; 8(9):1086-96. PubMed ID: 16832832
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation does not change the performance and characteristics of allogenic mesenchymal stem cells highly over-expressing a cytoplasmic therapeutic transgene for cancer treatment.
Ho YK; Loke KM; Woo JY; Lee YL; Too HP
Stem Cell Res Ther; 2022 Nov; 13(1):519. PubMed ID: 36376945
[TBL] [Abstract][Full Text] [Related]
5. Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.
Xing L; Sun X; Deng X; Kotedia K; Urano M; Koutcher JA; Ling CC; Li GC
Radiother Oncol; 2009 Sep; 92(3):345-52. PubMed ID: 19433338
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
Nouri FS; Wang X; Hatefi A
J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
[TBL] [Abstract][Full Text] [Related]
7. A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth.
Tu GXE; Ho YK; Ng ZX; Teo KJ; Yeo TT; Too HP
Stem Cell Res Ther; 2020 Sep; 11(1):391. PubMed ID: 32917269
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth.
Cavarretta IT; Altanerova V; Matuskova M; Kucerova L; Culig Z; Altaner C
Mol Ther; 2010 Jan; 18(1):223-31. PubMed ID: 19844197
[TBL] [Abstract][Full Text] [Related]
12. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
15. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
16. Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy.
Carvalho LA; Teng J; Fleming RL; Tabet EI; Zinter M; de Melo Reis RA; Tannous BA
J Natl Cancer Inst; 2019 Mar; 111(3):283-291. PubMed ID: 30257000
[TBL] [Abstract][Full Text] [Related]
17. SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.
Gonzalez-Junca A; Liu FD; Nagaraja AS; Mullenix A; Lee CT; Gordley RM; Frimannsson DO; Maller O; Garrison BS; Iyer D; Benabbas A; Truong TA; Quach A; Tian M; Martinez R; Savur R; Perry-McNamara A; Nguyen D; Almudhfar N; Blanco C; Huynh C; Nand A; Lay YE; Magal A; Mangalampalli S; Lee PJ; Lu TK; Lee G
Mol Cancer Ther; 2021 Sep; 20(9):1508-1520. PubMed ID: 34210826
[TBL] [Abstract][Full Text] [Related]
18. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
[TBL] [Abstract][Full Text] [Related]
19. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
